Dewen Mao
Impact in
- Hepatology top 10%
- Liver Disease and Transplantation
-
- Drug-Induced Hepatotoxicity and Protection
- Pharmacological Effects of Natural Compounds
Papers in
- Epidemiology 21
- Liver Disease Diagnosis and Treatment 19
- Hepatitis B Virus Studies 5
- Hepatology 12
- Liver Disease and Transplantation 10
- Co-authors
- Hua Qiu (9 shared papers)Rongzhen Zhang (10 shared papers)Na Wang (7 shared papers)Hanmin Li (2 shared papers)Fangyuan Gao (2 shared papers)Xiaodan Li (1 shared paper)Zuojiong Gong (2 shared papers)Qianqian Zhang (2 shared papers)
- Journals
- Evidence-based Complementary and Alternative Medicine (5 papers)Scientific Reports (2 papers)BMC Gastroenterology (2 papers)Phytotherapy Research (1 paper)FEBS Letters (1 paper)
- Partner nations
- China
In The Last Decade
Dewen Mao
26 papers receiving 198 citations
Peers
Comparison fields: 5 of 62
- Hepatology 65
- Pharmacology 40
- Complementary and alternative medicine 31
- Epidemiology 78
- Cancer Research 22
Countries citing papers authored by Dewen Mao
This map shows the geographic impact of Dewen Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dewen Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dewen Mao more than expected).
Fields of papers citing papers by Dewen Mao
This network shows the impact of papers produced by Dewen Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dewen Mao. The network helps show where Dewen Mao may publish in the future.
Co-authors
The 25 scholars most cited alongside Dewen Mao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | An experimental study on drugs for improving blood circulation and removing blood stasis in treating mild chronic hepatic damage. | 2001 | 33 |
| 2 | 2015 | 26 | |
| 3 | 2020 | 20 | |
| 4 | 2018 | 16 | |
| 5 | 2018 | 14 | |
| 6 | 2020 | 12 | |
| 7 | 2017 | 10 | |
| 8 | 2022 | 9 | |
| 9 | 2017 | 8 | |
| 10 | 2022 | 7 | |
| 11 | 2021 | 7 | |
| 12 | 2019 | 7 | |
| 13 | 2023 | 5 | |
| 14 | 2022 | 5 | |
| 15 | 2023 | 4 | |
| 16 | 2015 | 4 | |
| 17 | 2020 | 4 | |
| 18 | 2025 | 3 | |
| 19 | 2022 | 3 | |
| 20 | 2019 | 3 |
About Dewen Mao
Dewen Mao is a scholar working on Epidemiology, Hepatology, Pharmacology, Molecular Biology and Cancer Research, having authored 31 papers that have together received 207 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (19 papers), Liver Disease and Transplantation (10 papers), Drug-Induced Hepatotoxicity and Protection (8 papers), Hepatitis B Virus Studies (5 papers), MicroRNA in disease regulation (3 papers), Pharmacological Effects of Natural Compounds (3 papers), Gut microbiota and health (2 papers) and Cancer Mechanisms and Therapy (2 papers). The work is most often cited by research in Hepatology (65 citations), Pharmacology (40 citations), Complementary and alternative medicine (31 citations), Epidemiology (78 citations) and Cancer Research (22 citations). Dewen Mao has collaborated with scholars based in China. Frequent co-authors include Hua Qiu, Rongzhen Zhang, Na Wang, Hanmin Li, Fangyuan Gao, Xiaodan Li, Zuojiong Gong, Qianqian Zhang, Guoliang Chen and Yong‐Liang Chu. Their work appears in journals such as Evidence-based Complementary and Alternative Medicine, Scientific Reports, BMC Gastroenterology, Phytotherapy Research and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.